FDA 510(k)

综合节段性翻修系统（SRS）

K号: K173411 · 2018-02-08

决定日期2018-02-08

产品代码PHX

咨询委员会OR 请注意，由于原文中未提供具体的医疗设备监管文本，以下是一个示例翻译，您可以根据实际文本进行调整： --- 产品名称：[产品名称] 公司名称：[公司名称] 根据FDA 510(k)预市场批准程序，[产品名称]已获得批准，用于[产品用途描述]。产品注册号：[注册号] PMA编号：[PMA编号] 临床试验编号（NCT）：[NCT编号] PubMed ID（PMID）：[PMID编号] 更多信息请访问以下链接： [URL] --- 请将上述示例中的[产品名称]、[公司名称]、[注册号]、[PMA编号]、[NCT编号]、[PMID编号]和[URL]替换为实际的文本内容。

决定实质等同

器械摘要

Comprehensive Segmental Revision System (SRS) is the device name listed in this FDA 510(k) record. The listed applicant is Biomet Manufacturing Corp. It received FDA 510(k) clearance on 2018-02-08 under 510(k) number K173411. The device is classified under product code PHX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Comprehensive Segmental Revision System (SRS)?

Comprehensive Segmental Revision System (SRS) is a medical device that received FDA 510(k) clearance on 2018-02-08. The listed applicant is Biomet Manufacturing Corp. The 510(k) number is K173411.

When did Comprehensive Segmental Revision System (SRS) receive FDA 510(k) clearance?

Comprehensive Segmental Revision System (SRS) received FDA 510(k) clearance on 2018-02-08, under 510(k) number K173411.

Who is the listed applicant for Comprehensive Segmental Revision System (SRS)?

The FDA 510(k) record lists Biomet Manufacturing Corp as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Comprehensive Segmental Revision System (SRS)?

The FDA product code for Comprehensive Segmental Revision System (SRS) is PHX.

列明Biomet Manufacturing Corp为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K230540患者特异性规划解决方案™ 3D骨骼模型 K214001Comprehensive®肩关节系统，Comprehensive®反肩关节系统 K211729Comprehensive®可转换肩胛窝 - Vivacit-E衬里 K202232综合胸腔重建系统 K193038综合肩关节系统 K182516综合纳米无肩峰肩关节

查看所有 15 个设备 →

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。